13F HOLDINGS REPORT
Affinity Asset Advisors, LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001387131-23-006541
Total Value
$303.0M
Positions
74
Other Managers
0
Confidential Omitted
No
Holdings (74)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CHINOOK THERAPEUTICS INC | 16961L106 | 976,021 | $22.6M | 7.46% |
| 2 | MADRIGAL PHARMACEUTICALS INC | MDGL | 93,000 | $22.5M | 7.44% |
| 3 | SPDR S&P 500 ETF TRTR UNIT | SPY | 45,000 | $18.4M | 6.08% |
| 4 | PROMETHEUS BIOSCIENCES INC | 74349U108 | 150,000 | $16.1M | 5.31% |
| 5 | MERCK & CO INC | MRK | 120,000 | $12.8M | 4.21% |
| 6 | VIKING THERAPEUTICS INC | VKTX | 622,249 | $10.4M | 3.42% |
| 7 | CYMABAY THERAPEUTICS INC | 23257D103 | 1,083,118 | $9.4M | 3.12% |
| 8 | CEREVEL THERAPEUTICS HLDNG I | 15678U128 | 380,000 | $9.3M | 3.06% |
| 9 | VERONA PHARMA PLC | 925050106 | 452,821 | $9.1M | 3.00% |
| 10 | VENTYX BIOSCIENCES INC | 92332V107 | 260,008 | $8.7M | 2.87% |
| 11 | CYTOKINETICS INC | CYTK | 221,463 | $7.8M | 2.57% |
| 12 | ESTABLISHMENT LABS HLDGS INC | ESTA | 113,224 | $7.7M | 2.53% |
| 13 | BRIDGEBIO PHARMA INC | BBIO | 10,000,000 | $7.4M | 2.45% |
| 14 | BRIDGEBIO PHARMA INC | BBIO | 11,000,000 | $7.1M | 2.35% |
| 15 | ASTRIA THERAPEUTICS INC | 04635X102 | 529,369 | $7.0M | 2.32% |
| 16 | BRIDGEBIO PHARMA INC | BBIO | 389,800 | $6.5M | 2.13% |
| 17 | BELLUS HEALTH INC NEW | 07987C204 | 881,329 | $6.3M | 2.09% |
| 18 | ARCELLX INC | ACLX | 202,834 | $6.2M | 2.06% |
| 19 | MODERNA INC | MRNA | 35,000 | $5.4M | 1.77% |
| 20 | BRIDGEBIO PHARMA INC | BBIO | 320,000 | $5.3M | 1.75% |
| 21 | MORPHIC HLDG INC | 61775R105 | 135,863 | $5.1M | 1.69% |
| 22 | KURA ONCOLOGY INC | KURA | 357,287 | $4.4M | 1.44% |
| 23 | INOZYME PHARMA INC | 45790W108 | 751,796 | $4.3M | 1.42% |
| 24 | ASCENDIS PHARMA A/S | ASND | 40,000 | $4.3M | 1.42% |
| 25 | ASTRAZENECA PLC | AZN | 60,000 | $4.2M | 1.37% |
| 26 | SEAGEN INC | SE | 20,000 | $4.0M | 1.34% |
| 27 | ARGENX SE | ARGX | 10,750 | $4.0M | 1.32% |
| 28 | ASTRAZENECA PLC | AZN | 50,000 | $3.5M | 1.15% |
| 29 | XENON PHARMACEUTICALS INC | XENE | 90,000 | $3.2M | 1.06% |
| 30 | 89BIO INC | 282559103 | 200,000 | $3.0M | 1.01% |
| 31 | ESPERION THERAPEUTICS INC NE | ESPR | 7,500,000 | $3.0M | 0.99% |
| 32 | CENTESSA PHARMACEUTICALS PLC | CNTA | 684,127 | $2.6M | 0.87% |
| 33 | VIRIDIAN THERAPEUTICS INC | VRDN | 100,500 | $2.6M | 0.84% |
| 34 | LANTHEUS HLDGS INC | LNTH | 30,244 | $2.5M | 0.82% |
| 35 | BIOMARIN PHARMACEUTICAL INC | BMRN | 25,000 | $2.4M | 0.80% |
| 36 | NOVAVAX INC | NVAX | 346,800 | $2.4M | 0.79% |
| 37 | VAXCYTE INC | PCVX | 62,223 | $2.3M | 0.77% |
| 38 | APELLIS PHARMACEUTICALS INC | APLS | 35,000 | $2.3M | 0.76% |
| 39 | MIRUM PHARMACEUTICALS INC | MIRM | 95,000 | $2.3M | 0.75% |
| 40 | KARUNA THERAPEUTICS INC | 48576A100 | 12,500 | $2.3M | 0.75% |
| 41 | HORIZON THERAPEUTICS PUB L | G46188101 | 20,000 | $2.2M | 0.72% |
| 42 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 247,891 | $1.9M | 0.63% |
| 43 | CELLDEX THERAPEUTICS INC NEW | CLDX | 50,000 | $1.8M | 0.59% |
| 44 | KARYOPHARM THERAPEUTICS INC | KPTI | 460,979 | $1.8M | 0.59% |
| 45 | KALVISTA PHARMACEUTICALS INC | KALV | 208,292 | $1.6M | 0.54% |
| 46 | VIKING THERAPEUTICS INC | VKTX | 93,900 | $1.6M | 0.52% |
| 47 | VINCERX PHARMA INC | VNCE | 1,492,771 | $1.6M | 0.51% |
| 48 | COGENT BIOSCIENCES INC | COGT | 143,064 | $1.5M | 0.51% |
| 49 | PRECIGEN INC | PGEN | 1,500,000 | $1.5M | 0.48% |
| 50 | NURIX THERAPEUTICS INC | NRIX | 150,000 | $1.3M | 0.44% |
| 51 | LIANBIO | LIANY | 650,000 | $1.3M | 0.42% |
| 52 | INARI MED INC | 45332Y109 | 20,000 | $1.2M | 0.41% |
| 53 | ADC THERAPEUTICS SA | ADCT | 600,000 | $1.2M | 0.39% |
| 54 | POINT BIOPHARMA GLOBAL INC | 730541109 | 149,586 | $1.1M | 0.36% |
| 55 | ACLARIS THERAPEUTICS INC | ACRS | 129,100 | $1.0M | 0.34% |
| 56 | MINERALYS THERAPEUTICS INC | MLYS | 62,500 | $978,750 | 0.32% |
| 57 | THESEUS PHARMACEUTICALS INC | 88369M101 | 98,221 | $872,202 | 0.29% |
| 58 | BIOATLA INC | BCAB | 325,000 | $871,000 | 0.29% |
| 59 | JASPER THERAPEUTICS INC | JSPRW | 476,948 | $863,276 | 0.28% |
| 60 | FOGHORN THERAPEUTICS INC | FHTX | 136,771 | $847,980 | 0.28% |
| 61 | MILESTONE PHARMACEUTICALS IN | MIST | 199,382 | $785,565 | 0.26% |
| 62 | ROIVANT SCIENCES LTD | ROIV | 100,000 | $738,000 | 0.24% |
| 63 | ESPERION THERAPEUTICS INC NE | ESPR | 350,000 | $556,500 | 0.18% |
| 64 | 89BIO INC | 282559103 | 36,200 | $551,326 | 0.18% |
| 65 | PUMA BIOTECHNOLOGY INC | PBYI | 177,349 | $548,008 | 0.18% |
| 66 | NLS PHARMACEUTICS LTD | H57830103 | 344,089 | $519,574 | 0.17% |
| 67 | NUVATION BIO INC | NUVB | 250,000 | $415,000 | 0.14% |
| 68 | GLYCOMIMETICS INC | 38000Q102 | 300,000 | $378,000 | 0.12% |
| 69 | PIERIS PHARMACEUTICALS INC | 720795103 | 306,950 | $299,583 | 0.10% |
| 70 | IMMATICS N.V | IMTX | 187,204 | $269,574 | 0.09% |
| 71 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 37,000 | $68,450 | 0.02% |
| 72 | SCILEX HOLDING CO | SCLXW | 18,099 | $19,004 | 0.01% |
| 73 | ROCKET PHARMACEUTICALS INC | RCKTW | 75,000 | $12,255 | 0.00% |
| 74 | SCILEX HOLDING CO | SCLXW | 463 | $3,797 | 0.00% |